Yamamoto S, Ohmoto K, Ideguchi S, Yamamoto R, Mitsui Y, Shimabara M, Iguchi Y, Ohumi T, Takatori K
Division of Gastroenterology (I), Kawasaki Medical School.
Nihon Shokakibyo Gakkai Zasshi. 1994 Jul;91(7):1205-9.
We administered 3 g of taurine orally for four weeks to 35 patients suffering from liver cirrhosis with repeated muscle cramp (MC). Improvement of MC was noted in 22 cases (62.9%). We also determined the plasma taurine concentration in eight cases of liver cirrhosis with MC. The plasma taurine concentration before ingestion was 54.1 +/- 20.7 nmol/ml, whereas that of four weeks after ingestion was 125.1 +/- 59.1 nmol/ml, which was significantly elevated by 2.3 fold. As the concentration increased, the frequency of MC decreased, suggesting the good correlation between ingestion and the decrease in frequency of MC. In liver cirrhosis without MC the plasma taurine concentration was 81.0 +/- 16.7 nmol/ml, which was significantly higher than in liver cirrhosis with MC. In a few cases with taurine ingestion, serial plasma taurine concentrations were detected. Plasma taurine reached the peak value during the first week of ingestion and plasma taurine levels were maintained 2-5 fold higher during ingestion.
我们对35例患有反复肌肉痉挛(MC)的肝硬化患者口服给予3克牛磺酸,为期四周。22例(62.9%)患者的MC症状有所改善。我们还测定了8例患有MC的肝硬化患者的血浆牛磺酸浓度。摄入前血浆牛磺酸浓度为54.1±20.7纳摩尔/毫升,而摄入四周后为125.1±59.1纳摩尔/毫升,显著升高了2.3倍。随着浓度增加,MC的发作频率降低,表明摄入与MC发作频率降低之间存在良好的相关性。在无MC的肝硬化患者中,血浆牛磺酸浓度为81.0±16.7纳摩尔/毫升,显著高于患有MC的肝硬化患者。在少数摄入牛磺酸的病例中,检测了系列血浆牛磺酸浓度。血浆牛磺酸在摄入的第一周达到峰值,摄入期间血浆牛磺酸水平维持在高2 - 5倍的水平。